5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (vol 12, pg 233, 2024)

被引：0
|
作者：
Lean, Michael E. J.
Leslie, Wilma S.
Barnes, Alison C.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2024年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e17 / e17
页数：1
相关论文
共 8 条
  • [1] 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
    Lean, Michael E. J.
    Leslie, Wilma S.
    Barnes, Alison C.
    Brosnahan, Naomi
    Thom, George
    McCombie, Louise
    Kelly, Tara
    Irvine, Keaton
    Peters, Carl
    Zhyzhneuskaya, Sviatlana
    Hollingsworth, Kieren G.
    Adamson, Ashley J.
    Sniehotta, Falko F.
    Mathers, John C.
    McIlvenna, Yvonne
    Welsh, Paul
    McConnachie, Alex
    McIntosh, Alasdair
    Sattar, Naveed
    Taylor, Roy
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (04): : 233 - 246
  • [2] 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (vol 374, pg 1677, 2009)
    Bray, G. A.
    [J]. LANCET, 2009, 374 (9707): : 2054 - 2054
  • [3] Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study (vol 12, pg 2595, 2017)
    Yu, Chengkai
    Song, Yufei
    Qi, Yangyang
    Li, Chanjuan
    Jiang, Zhiwei
    Li, Chen
    Zhang, Wei
    Wang, Ling
    Xia, Jielai
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (01) : 249 - 249
  • [4] Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in female outpatients with anorexia nervosa (ANTOP study): 5-year follow-up of a randomised controlled trial in Germany (vol 9, pg 280, 2022)
    Herzog, W.
    Wild, B.
    Giel, K. E.
    [J]. LANCET PSYCHIATRY, 2022, 9 (06): : E23 - E23
  • [5] Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial (vol 7, pg e866, 2022)
    Ahern, A. L.
    Breeze, P.
    Fusco, F.
    [J]. LANCET PUBLIC HEALTH, 2022, 7 (11): : E896 - E896
  • [6] Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ornbjerg, Lykke Midtboll
    Ejbjerg, Bo
    Hetland, Merete Lund
    Moller, Jakob Mollenbach
    Nielsen, Sabrina Mai
    Glinatsi, Daniel
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Christensen, Robin
    Ostergaard, Mikkel
    [J]. RMD OPEN, 2024, 10 (01):
  • [7] Phase III randomised trial of high-dose chemotherapy and peripheral blood stem cell support as consolidation in patients with advanced ovarian cancer: 5-year follow-up of a GINECO/FNCLCC/SFGM-TC study
    Cure, H
    Battista, C
    Biron, P
    Bay, JO
    Lotz, J
    Lioures, B
    Chiurazzi, B
    Bourgeois, H
    Fabbro, M
    Paraiso, D
    Pujade-Lauraine, E
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S52 - S52
  • [8] Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial (vol 402, pg 1979, 2023)
    Iglesias, J. F.
    Roffi, M.
    Losdat, S.
    [J]. LANCET, 2023, 402 (10416): : 1978 - 1978
1